IRS Ruling on Genetic Testing Services as Medical Care

In a private letter ruling (“PLR”) released August 16, 2019, the IRS ruled that a taxpayer can allocate the cost of a DNA collection kit and related health services between non-medical ancestry services and health services that are medical care for tax purposes. Thus, a portion of the cost could be reimbursed by a health flexible spending account (FSA) or other account-based health plan.

Please click on the following link for more information.

IRS Ruling on Genetic Testing Services as Medical Care – 091219R

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *